Glibenclamide–sulfonylurea receptor 1 antagonist alleviates LPS-induced BV2 cell activation through the p38/MAPK pathway.
| Autor: | Xu, Zhiming, Liu, Yingliang, Yang, Dianxu, Yuan, Fang, Ding, Jun, Wang, Liping, Qu, Meijie, Yang, Guoyuan, Tian, Hengli |
|---|---|
| Zdroj: | RSC Advances; 2017, Vol. 7 Issue 44, p27206-27213, 8p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|